Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Buprenorphine/clonazepam/sertraline

Neonatal abstinence syndrome: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tabi S, et al. Opioid Addiction/Pregnancy and Neonatal Abstinence Syndrome (NAS): A Preliminary Open-Label Study of Buprenorphine Maintenance and Drug Use Targeted Psychotherapy (DUST) on Cessation of Addictive Drug Use. Frontiers in Psychiatry 11: Sep 2020. Available from: URL: http://doi.org/10.3389/fpsyt.2020.563409 Tabi S, et al. Opioid Addiction/Pregnancy and Neonatal Abstinence Syndrome (NAS): A Preliminary Open-Label Study of Buprenorphine Maintenance and Drug Use Targeted Psychotherapy (DUST) on Cessation of Addictive Drug Use. Frontiers in Psychiatry 11: Sep 2020. Available from: URL: http://​doi.​org/​10.​3389/​fpsyt.​2020.​563409
Metadaten
Titel
Buprenorphine/clonazepam/sertraline
Neonatal abstinence syndrome: case report
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-88014-4

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Infliximab

Case report

Multiple drugs